Use of in vivo nasal transepithelial potential difference to evaluate efficacy in CF gene therapy phase I trials
- PMID: 7875259
Use of in vivo nasal transepithelial potential difference to evaluate efficacy in CF gene therapy phase I trials
Comment on
-
Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.Eur Respir J. 1994 Nov;7(11):2050-6. Eur Respir J. 1994. PMID: 7875281
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical